Document is current
Any future updates will be listed below
-
Authors
Tsujisaka, Yuta
Yamashita, Yugo
Morimoto, Takeshi
Chatani, Ryuki
Kaneda, Kazuhisa
Nishimoto, Yuji
Ikeda, Nobutaka
Kobayashi, Yohei
Ikeda, Satoshi
Kim, Kitae
Inoko, Moriaki
Takase, Toru
Tsuji, Shuhei
Oi, Maki
Takada, Takuma
Otsui, Kazunori
Sakamoto, Jiro
Ogihara, Yoshito
Inoue, Takeshi
Usami, Shunsuke
Chen, Po-Min
Togi, Kiyonori
Koitabashi, Norimichi
Hiramori, Seiichi
Doi, Kosuke
Mabuchi, Hiroshi
Tsuyuki, Yoshiaki
Murata, Koichiro
Takabayashi, Kensuke
Nakai, Hisato
Sueta, Daisuke
Shioyama, Wataru
Dohke, Tomohiro
Nishikawa, Ryusuke
Ono, Koh
Kimura, Takeshi
,
-
Funding
Funding for this research was provided by:
Bayer Healthcare
Daiichi-Sankyo
Pfizer
- License Information
-
More Information
Article History
Accepted: 25 April 2025
First Online: 28 May 2025
Declarations
:
: Dr. Yamashita received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, Pfizer, and Daiichi-Sankyo, and grant support from Bayer Healthcare and Daiichi-Sankyo. Dr. Morimoto reports lecturer’s fees from Bristol-Myers Squibb, Daiichi Sankyo, Japan Lifeline, Kowa, Kyocera, Novartis, and Toray; manuscript fees from Bristol-Myers Squibb and Kowa; advisory board for Sanofi. Dr. Kaneda received lecture fees from Bristol-Myers Squibb, Pfizer, and Daiichi-Sankyo. Dr. Nishimoto received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, Pfizer, and Daiichi-Sankyo. Dr. Ikeda N. received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, and Daiichi-Sankyo. Dr. Ikeda S. received lecture fees from Bayer Healthcare, Bristol-Myers Squibb and Daiichi-Sankyo. Dr. Ogihara received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, Pfizer, and Daiichi-Sankyo, and a research fund from Bayer Healthcare. Dr. Koitabashi received lecture fees from Bayer Healthcare and grant support from Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
